About
DIA Labs Canada is a Mississauga-based medical device R&D company. Our flagship product, AirSense, is a Class II novel device designed for continuous asthma monitoring through the interstitial fluid (ISF). AirSense offers a real-time monitoring solution for both asthma patients and drug sponsors, supporting more effective disease management and clinical research.
long-arrow-right
